Chemoprevention of colorectal cancer

被引:29
|
作者
Raju, R
Cruz-Correa, M
机构
[1] Cleveland Clin Florida, Dept Med, Weston, FL USA
[2] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[3] Univ Puerto Rico, Comprehens Care Ctr, San Juan, PR 00936 USA
关键词
colorectal cancer; chemoprevention; adenomatous polyps; aspirin; nonsteroidal anti-inflammatory drugs;
D O I
10.1007/s10350-005-0170-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colorectal cancer is a major public health concern in all developed countries. Despite decades of advances in the treatment and prevention of colorectal cancer, it remains the second most common cause of cancer death. However, the optimal method for early detection remains unknown and patient compliance with screening recommendations remains poor. This has led to the development of complementary strategies, such as chemoprevention to reduce morbidity and mortality from colorectal cancer. Chemoprevention is defined as the use of specific pharmacologic or nutrient agents to prevent, reverse, or inhibit the process of carcinogenesis. This review was designed to discuss the most promising agents in colorectal chemoprevention.
引用
收藏
页码:113 / 124
页数:12
相关论文
共 50 条
  • [41] Current Status of Colorectal Cancer Chemoprevention
    Half, Elizabeth
    Sinicrope, Frank A.
    CURRENT COLORECTAL CANCER REPORTS, 2007, 3 (01) : 39 - 48
  • [43] Chemoprevention of colorectal cancer: Facts or fiction?
    Winde, G
    CHIRURGISCHE GASTROENTEROLOGIE, 2000, 16 (03): : 194 - 204
  • [44] Aspirin as a Chemoprevention Agent for Colorectal Cancer
    Lee, Chun Seng
    McNamara, Deirdre
    O'Morain, Colm A.
    CURRENT DRUG METABOLISM, 2012, 13 (09) : 1313 - 1322
  • [45] Mechanisms of aspirin chemoprevention of colorectal cancer
    Vainio, H
    Morgan, G
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (04) : 289 - 292
  • [46] Colorectal cancer chemoprevention - An overview of the science
    Hawk, ET
    Umar, A
    Viner, JL
    GASTROENTEROLOGY, 2004, 126 (05) : 1423 - 1447
  • [47] Chemoprevention in hereditary colorectal cancer syndromes
    Hawk, E
    Lubet, R
    Limburg, P
    CANCER, 1999, 86 (11) : 2551 - 2563
  • [48] Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
    Marin, Jose J. G.
    Sanchez de Medina, Fermin
    Castano, Beatriz
    Bujanda, Luis
    Romero, Marta R.
    Martinez-Augustin, Olga
    Del Moral-Avila, Rosario
    Briz, Oscar
    DRUG METABOLISM REVIEWS, 2012, 44 (02) : 148 - 172
  • [49] Ursodeoxycholic acid and chemoprevention of colorectal cancer
    Serfaty, L.
    Bissonnette, M.
    Poupon, R.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (10): : 516 - 522
  • [50] Chemoprevention of colorectal cancer in ulcerative colitis
    Thomson, A
    INTERNAL MEDICINE JOURNAL, 2006, 36 (08) : 540 - 540